It is usually difficult to find a solution that will deal with all your corporate demands or offers you appropriate instruments to deal with document creation and approval. Opting for an application or platform that combines crucial document creation instruments that simplify any task you have in mind is crucial. Even though the most in-demand formatting to use is PDF, you require a comprehensive software to deal with any available formatting, such as AMI.
DocHub ensures that all your document creation demands are covered. Revise, eSign, rotate and merge your pages according to your preferences by a mouse click. Deal with all formats, such as AMI, successfully and quick. Regardless of the formatting you start dealing with, you can easily change it into a needed formatting. Save a great deal of time requesting or looking for the appropriate file format.
With DocHub, you do not need extra time to get accustomed to our user interface and editing process. DocHub is undoubtedly an easy-to-use and user-friendly software for anybody, even all those without a tech education. Onboard your team and departments and change file administration for the organization forever. void frame in AMI, generate fillable forms, eSign your documents, and have things done with DocHub.
Benefit from DocHub’s extensive function list and easily work on any file in any formatting, including AMI. Save your time cobbling together third-party platforms and stay with an all-in-one software to enhance your everyday procedures. Begin your free of charge DocHub trial subscription right now.
[Music] welcome to esc tv barcelona were here at the esc 2022 in barcelona and im joined here by my colleague joe young han from korea to discuss the results of the frame ami trial i am stefan james professor of cardiology upsell university in sweden jo young you presented your results yesterday you were addressing an important clinical question how we should identify lesions to revascularize in patients with multivessen disease suffering from acs stemi or non-stemi can you please briefly tell the tell us about the results of your trial yeah we compared ffa guided pci versus angiography guided pci for a treatment of non-inflammated artery lesions but the primary endpoint of our study was the composite of death mi and the repeat with vascularization so we ignored 562 patients and we randomly assigned these patients to the ffa guided pci group or angiography guided pci group in a one-ton fashion during a three and a half years median follow-up the primary endpoint occurred less freque